Keywords: Diagnosis/Prediction, Spectroscopy
Motivation: To investigate the potential of macromolecule (MM) from 1HMRS as biomarkers for Alzheimer's Disease (AD).
Goal(s): Enhance the MRS-only diagnostic prediction for the AD continuum by incorporating MM data.
Approach: We predict the diagnosis of 143 individuals ranging from cognitively healthy to AD using only 1HMRS data, employing OPLSDA. We compare the model's performance with/without MM and validate the results with a second ML classifier. We also evaluate variable importance in classification.
Results: The inclusion of MM signals improves AD diagnosis prediction when OPLSDA is used. Various MM peaks contribute to the classification. However, the transitional stage of MCI cannot be accurately classified.
Impact: When combined with the appropriate method, MM signals can enhance the diagnosis of AD using MRS as a stand-alone marker, and important MM peaks belonging to the AD neurochemical fingerprint were identified.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords